Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Dignity Therapy Applied to End-stage Cancer Patients on Perceived Dignity and Self-esteem: a Randomized Controlled Trial

NCT06105359 is registered in ClinicalTrials.gov with Necmettin Erbakan University as lead sponsor.

NCT NCT06105359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06105359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Dignity Therapy Applied to End-stage Cancer Patients on Perceived Dignity and Self-esteem: a Randomized Controlled Trial
Lead sponsor
Necmettin Erbakan University
Phase
Not applicable
Overall status
Completed
Start date
January 12, 2023
Completion date
September 15, 2025
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, dignity